SCHEMBL4380349

SCHEMBL4380349

[CH2]CNc1nc(NCc2cccc(Cl)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
PRKCQ Q04759 3/20 0.50
SIRT5 Q9NXA8 2/20 0.46
MAP4K4 O95819 1/20 0.45
TXNRD1 Q16881 1/20 0.42
EGFR P00533 2/20 0.41
IGF1R P08069 2/20 0.41
RECQL P46063 1/20 0.40
APP P05067 1/20 0.40
IDO1 P14902 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
PDE5A O76074 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384924 0.87 MAPT (0.54) MAPTPRKCQSIRT5EGFRIGF1R
SCHEMBL4392529 0.86 MAPT (0.48) MAPTPRKCQSIRT5IDO1NPC1
SCHEMBL4379701 0.85 MAPT (0.46) MAPTPRKCQSIRT5NPC1ALDH1A1
SCHEMBL4387612 0.84 PRKCQ (0.68) PRKCQSIRT5MAP4K4
SCHEMBL1182286 0.82 MAPT (0.56) MAPTPRKCQSIRT5MAP4K4TXNRD1
SCHEMBL10353602 0.72 MAPT (0.72) MAPTPRKCQEGFRIGF1RRECQL
SCHEMBL1182094 0.72 MAPT (0.52) MAPTSIRT5APPNPC1ALDH1A1
SCHEMBL4380044 0.71 PRKCQ (0.69) PRKCQSIRT5L3MBTL1
SCHEMBL1748266 0.71 MAPT (0.51) MAPTPRKCQEGFRIGF1RAPP
SCHEMBL16586038 0.71 PRKCQ (0.64) MAPTPRKCQMAP4K4EGFRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066665-A2 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2009-06-10 EP disclosed
WO-2008043087-A2 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2008-04-10 WO disclosed